OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.

Biotechnology

OncoNano Medicine

OncoNano Medicine's headquarters in Southlake, TX, United States

Kathy Rath

Matthew Head

Angie Haar

Tian Zhao

Kartik Krishnan

Ruolan Han

Bhargavi Allu

Coby White

Jason Miller

John Dyett

John Niederhuber

Yumin Qiu

Paul Bunn

Raphael Pollock

Baran Sumer

Charles Balch

Alexander Eggermont

Brett Giroir

Gina Guillem Jones

The Leadership Team at OncoNano Medicine is responsible for setting the strategic direction of the company and overseeing operations across various functions, including clinical, technical, regulatory, financial, and research. By leveraging their expertise, the team ensures the successful development and commercialization of innovative pH-activated therapeutics and imaging agents, driving advancements in targeted medicine for disease. Their collaborative efforts foster a cohesive vision, enabling the company to navigate complex challenges while focusing on improving patient outcomes.

Leadership Team

The Regulatory and Compliance Team at OncoNano Medicine ensures that all products and processes comply with applicable regulatory standards and guidelines. This team plays a critical role in navigating the complex regulatory landscape, overseeing the development of pH-activated compounds, and facilitating submissions to regulatory bodies. By collaborating closely with scientific advisors and clinical operations, they help advance innovative therapeutics and imaging agents from concept to market while maintaining the highest standards of safety and efficacy.

Regulatory and Compliance Team

The Finance and Operations Team at OncoNano Medicine is responsible for managing financial strategies and operational efficiency to support the company's innovative pipeline of pH-activated therapeutics. They oversee budgeting, forecasting, and financial planning while ensuring that operational processes align with strategic goals, facilitating effective resource allocation and maximization of organizational performance. Their expertise enables OncoNano to seamlessly integrate financial oversight with technical operations, driving advancements in targeted disease treatment.

Finance and Operations Team

The Research and Development Team at OncoNano Medicine focuses on advancing the company's innovative pH-activated compounds by conducting cutting-edge research and optimizing therapeutic and imaging agents. This team collaborates closely to explore pH variability in disease, driving the development of targeted solutions that enhance identification and treatment of diseased tissues, ultimately contributing to the company's mission of transforming cancer care.

Research and Development Team

OncoNano Medicine

Org chart

Board & advisors

Teams

Leadership Team

Regulatory and Compliance Team

Finance and Operations Team

Research and Development Team

Offices

OncoNano Medicine

Org chart

Board & advisors

Teams

Leadership Team

Regulatory and Compliance Team

Finance and Operations Team

Research and Development Team

Offices

Related companies